|
|
|
|
The primacy of public health considerations in defining poor quality medicines
|
|
|
|
|
|
|
|
نویسنده
|
newton p.n. ,amin a.a. ,bird c. ,passmore p. ,dukes g. ,tomson g. ,simons b. ,bate r. ,guerin p.j. ,white n.j.
|
|
منبع
|
plos medicine - 2011 - دوره : 8 - شماره : 12
|
|
چکیده
|
[no abstract available]
|
|
|
|
|
آدرس
|
wellcome trust-mahosot hospital-oxford tropical medicine research collaboration,microbiology laboratory,mahosot hospital,vientiane,laos,centre for tropical medicine,nuffield department of medicine,university of oxford,churchill hospital,oxford,united kingdom,worldwide antimalarial resistance network (wwarn),university of oxford,oxford, United Kingdom, malaria and child survival department,population services international,nairobi, Kenya, wellcome trust,london, United Kingdom, school of pharmacy,curtin university of technology,bentley,wa, Australia, university of oslo,oslo, Norway, ihcar div global health,karolinska institute,stockholm, Sweden, imani center for policy and education,accra, Ghana, american enterprise institute,washington,d.c., United States, centre for tropical medicine,nuffield department of medicine,university of oxford,churchill hospital,oxford,united kingdom,worldwide antimalarial resistance network (wwarn),university of oxford,oxford, United Kingdom, centre for tropical medicine,nuffield department of medicine,university of oxford,churchill hospital,oxford,united kingdom,mahidol oxford research unit,faculty of tropical medicine,mahidol university,bangkok, Thailand
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|